Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA174047 ID: 174047

Homo sapiens (human)

Gene expression profiling in primary AML cells treated with decitabine and cytarabine

See Genome Information for Homo sapiens
Acute myeloid leukemia (AML), and other myeloid malignancies, are frequently treated with hypomethylating agents like decitabine. More...
AccessionPRJNA174047; GEO: GSE40442
Data TypeTranscriptome or Gene expression
ScopeMultiisolate
OrganismHomo sapiens[Taxonomy ID: 9606]
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
PublicationsKlco JM et al., "Genomic impact of transient low-dose decitabine treatment on primary AML cells.", Blood, 2013 Feb 28;121(9):1633-43
SubmissionRegistration date: 28-Aug-2012
Washington University in St.Louis
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Publications
PubMed1
PMC1
Other datasets
GEO DataSets1
GEO Data Details
ParameterValue
Data volume, Spots58825062
Data volume, Processed Mbytes892
Data volume, Supplementary Mbytes1422

Supplemental Content

Recent activity

  • Sparassis crispa strain:FP-133458
    Sparassis crispa strain:FP-133458
    Sparassis crispa FP-133458 genome sequencing
    BioProject
  • Polymorphobacter arshaanensis strain:DJ1R-1
    Polymorphobacter arshaanensis strain:DJ1R-1
    Polymorphobacter arshaanensis strain:DJ1R-1 Genome sequencing and assembly
    BioProject
  • Streptomyces sp. LUP30
    Streptomyces sp. LUP30
    Streptomyces sp. LUP30 Genome sequencing and assembly
    BioProject
  • Fungus
    Fungus
    Metagenomic analysis of fungal diversity from Raw Milk Fermented product Dahi
    BioProject
  • Homo sapiens
    Homo sapiens
    Gene expression profiling in primary AML cells treated with decitabine and cytarabine
    BioProject

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center